Ligand ID: CFB Drugbank ID: DB00631(Clofarabine) Indication:For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphocytic (lymphoblastic) leukemia after at least two prior regimens. It is designated as an orphan drug by the FDA for this use. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 2A7Q_A_CFBA328_1 (DEOXYCYTIDINE KINASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLU A 254VAL A 320ARG A 183ARG A 285GLU A 278 | 1.70A | 14.95 | None | ||
![]() | 2A7Q_A_CFBA328_2 (DEOXYCYTIDINE KINASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | ILE A 548ASP A 833LEU A 437ARG A 858 | 1.73A | 14.95 | None | ||
![]() | 2A7Q_A_CFBA328_1 (DEOXYCYTIDINE KINASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLU A 143MET A 84TYR A 83ARG A 138TYR A 72 | 1.56A | 19.19 | None | ||
![]() | 2A7Q_A_CFBA328_1 (DEOXYCYTIDINE KINASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLU C 143MET C 84TYR C 83ARG C 138TYR C 72 | 1.68A | 19.19 | None | ||
![]() | 2A7Q_A_CFBA328_2 (DEOXYCYTIDINE KINASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | ILE A 548ASP A 833LEU A 437ARG A 858 | 1.67A | 14.95 | None |